CorMedix, Inc. (CRMD)
8.945
+0.18
(+2.00%)
USD |
NASDAQ |
Jun 11, 16:00
8.98
+0.04
(+0.39%)
After-Hours: 20:00
CorMedix Total Liabilities (Quarterly) : 378.59M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 378.59M |
| December 31, 2025 | 472.32M |
| September 30, 2025 | 376.73M |
| June 30, 2025 | 31.97M |
| March 31, 2025 | 34.69M |
| December 31, 2024 | 34.19M |
| September 30, 2024 | 18.87M |
| June 30, 2024 | 11.55M |
| March 31, 2024 | 10.01M |
| December 31, 2023 | 11.92M |
| September 30, 2023 | 8.227M |
| June 30, 2023 | 7.982M |
| March 31, 2023 | 5.306M |
| December 31, 2022 | 6.978M |
| September 30, 2022 | 5.765M |
| June 30, 2022 | 6.009M |
| March 31, 2022 | 5.064M |
| December 31, 2021 | 6.148M |
| September 30, 2021 | 6.045M |
| June 30, 2021 | 3.988M |
| March 31, 2021 | 3.944M |
| December 31, 2020 | 5.085M |
| September 30, 2020 | 5.553M |
| June 30, 2020 | 5.716M |
| March 31, 2020 | 5.806M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.830M |
| September 30, 2019 | 5.010M |
| June 30, 2019 | 11.08M |
| March 31, 2019 | 10.77M |
| December 31, 2018 | 13.89M |
| September 30, 2018 | 17.55M |
| June 30, 2018 | 12.40M |
| March 31, 2018 | 8.768M |
| December 31, 2017 | 6.261M |
| September 30, 2017 | 4.252M |
| June 30, 2017 | 5.790M |
| March 31, 2017 | 3.89M |
| December 31, 2016 | 4.092M |
| September 30, 2016 | 5.061M |
| June 30, 2016 | 3.142M |
| March 31, 2016 | 3.090M |
| December 31, 2015 | 3.090M |
| September 30, 2015 | 2.915M |
| June 30, 2015 | 1.945M |
| March 31, 2015 | 2.156M |
| December 31, 2014 | 1.463M |
| September 30, 2014 | 1.267M |
| June 30, 2014 | 9.856M |
| March 31, 2014 | 13.49M |
| December 31, 2013 | 6.990M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.23M |
| Eloxx Pharmaceuticals, Inc. | 16.09M |
| Cannabis Global, Inc. | 6.178M |
| BioStem Technologies, Inc. | 23.21M |
| Axsome Therapeutics, Inc. | 659.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 815.64M |
| Shareholders Equity (Quarterly) | 437.05M |
| Debt to Equity Ratio | 0.3315 |
| Current Ratio | 2.975 |
| Net Debt Paydown Yield | -5.42% |